Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | |
| Cash Flows From Operating Activities | ||
| Net Income | -46,516 | N/A |
| Accounts payable and accrued liabilities | 1,726 | N/A |
| Other Working Capital | 628 | N/A |
| Other Operating Activity | 25,306 | 0 |
| Operating Cash Flow | $-18,856 | $N/A |
| Cash Flows From Investing Activities | ||
| Investing Cash Flow | $N/A | $N/A |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 2 | N/A |
| Other Financing Activity | 41,235 | 0 |
| Financing Cash Flow | $41,237 | $N/A |
| Beginning Cash Position | 13,623 | N/A |
| End Cash Position | 36,004 | N/A |
| Net Cash Flow | $22,381 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -18,856 | N/A |
| Free Cash Flow | -18,856 | 0 |